Context Therapeutics (NASDAQ:CNTX) Inc CEO Martin Lehr tells Proactive the women’s oncology company saw its third quarter as 'pivotal' for the group, following its debut on Nasdaq and a recent private placement of its units that extends its cash runway into 2024. Lehr says it also strengthened its leadership team with the addition of chief financial officer Jennifer Minai-Azary and chief legal officer Alex Levit, who was instrumental in getting Context Therapeutics (Context Therapeutics (NASDAQ:CNTX)) listed.
Context Therapeutics talks through 'pivotal' 3Q including recent $31.25M PIPE investment
